At Regultech Solutions Limited, we provide expert GXP, FDA 21 CFR Part 11, and EU GMP Annex 11 compliance services tailored for small biotech, pharmaceutical, and clinical research companies, ensuring precision and efficiency in meeting stringent GxP requirements.
Reach out to us for expert GXP, FDA 21 CFR Part 11 and EU GMP Annex 11 compliance support tailored for biotechnology and pharmaceutical industries.
17 King Edwards Road, Ruislip, London, United Kingdom, HA4 7AE
Phone: +44 079 49529863
Monday - Friday, 9:00 AM - 5:00 PM
info@regultechsolutions.com
Reach out to us anytime!
Navigate the complexities of regulatory compliance with our comprehensive FAQ. We've compiled answers to the most common questions about GxP, FDA regulations, and quality management in biotechnology and pharmaceutical industries.
GxP is an umbrella term for Good Practice guidelines and regulations in various industries, including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP). It ensures quality, safety, and efficacy in pharmaceutical, biotechnology, and medical device sectors.
FDA 21 CFR Part 11 provides guidelines for electronic records and electronic signatures, ensuring their reliability, trustworthiness, and equivalence to paper records. It's crucial for maintaining data integrity in regulated industries, particularly in pharmaceutical and clinical research.
Compliance audits should typically be conducted annually or whenever significant changes occur in processes, systems, or regulations. Regular internal audits help identify potential issues, ensure ongoing regulatory adherence, and maintain high-quality standards.
Non-compliance can result in severe consequences, including regulatory fines, product recalls, legal actions, loss of market authorization, damage to reputation, and potential suspension of business operations in regulated industries.
Navigating the complex landscape of regulatory compliance can be challenging. Our Frequently Asked Questions (FAQ) section is designed to provide clear, concise answers to the most common queries in GxP, FDA regulations, and quality management.
Whether you're a small biotechnology startup, a clinical research organization, or a pharmaceutical company, understanding these critical regulatory requirements is essential for maintaining quality, safety, and legal compliance.
Have questions regarding GXP, FDA 21 CFR Part 11, or EU GMP Annex 11 compliance? Fill out the form below, and our experts will provide you with the tailored guidance you need for your biotechnology, pharmaceutical, or clinical research company.